Stay Informed on Key Developments

Investor News and Updates

Bill_Ipad

Stay informed about key developments at our company as they happen. Discover our Ad-Hoc Releases and subscribe to our newsletter to receive the latest news and topics of interest.

81 - 90of 392 News

81 - 90of 392 News

January 10, 2023

Not intended for U.S. and U.K. Media

Bayer progressing well with transformation of pharma business and raises peak sales potential of key growth drivers to over twelve billion euros

December 16, 2022

Not intended for U.S. and UK Media

Finerenone receives positive CHMP opinion for EU-label extension for broad range of patients with chronic kidney disease and type 2 diabetes

December 14, 2022

Bayer recognized as leader on climate change for fifth consecutive year

November 11, 2022

Not intended for U.S. and UK Media

Bayer receives positive CHMP opinion for Eylea™ in the EU for treatment of preterm infants with retinopathy of prematurity

November 08, 2022

Third quarter of 2022

Bayer with continued strong performance

October 17, 2022

Not intended for U.S. and UK Media

Bayer expands development program for elinzanetant with Phase III study in breast cancer patients with vasomotor symptoms caused by endocrine therapy

October 05, 2022

Bayer completes sale of its Environmental Science Professional business to Cinven

September 08, 2022

Not intended for U.S. and UK Media

Aflibercept 8 mg first to achieve extended injection intervals of 16 weeks in up to 89% of patients

September 02, 2022

Not intended for U.S. and UK Media

Kerendia™ (finerenone) receives updated label in the U.S. to include findings from Phase III FIGARO-DKD cardiovascular outcomes study

September 01, 2022

Kimberly Mathisen appointed to the Supervisory Board of Bayer AG

Inform Yourself on Special Topics

Control Weeds Not Farming

Control Weeds, Not Farming

Farmers discussing their weed management

Everything You Need to Know About Glyphosate

some-bayer-group-headquarters

Managing Glyphosate Litigation

woman harvesting carrots

Managing and Mitigating PCB Litigation Risk